Revisiting the internal mammaries as recipient vessels in breast reconstruction: considerations in current practice Steven M. SultanAmanda M. RizzoKatie E. Weichman Review 04 September 2020 Pages: 255 - 264
Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway Arielle L. HeekeJoanne XiuAntoinette R. Tan Preclinical study 10 August 2020 Pages: 265 - 275
Androgen receptor expression is useful to predict the therapeutic effect in HER2-positive breast carcinoma Momoko AkashiRin YamaguchiHirohisa Yano Preclinical study 08 August 2020 Pages: 277 - 285
BTB domain-containing 7 predicts low recurrence and suppresses tumor progression by deactivating Notch1 signaling in breast cancer Jian ChenYuan-Hui LaiTian-Yu Liu Preclinical study 08 August 2020 Pages: 287 - 300
Receipt of psychological counseling and integrative medicine services among breast cancer survivors with anxiety Kelly M. TrevinoNeil IyengarJun J. Mao Preclinical study 09 August 2020 Pages: 301 - 310
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients Ramona ErberMatthias RübnerPeter A. Fasching Preclinical study Open access 27 August 2020 Pages: 311 - 324
Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer Ji-Yeon KimHae Hyun JungYoung-Hyuck Im Preclinical study 18 August 2020 Pages: 325 - 334
Factors affecting the number of sentinel lymph nodes removed in patients having surgery for breast cancer J. Michael DixonJulia GrewarArran Turnbull Clinical trial Open access 18 August 2020 Pages: 335 - 343
The impact of co-surgeons on complication rates and healthcare cost in patients undergoing microsurgical breast reconstruction: analysis of 8680 patients Malke AsaadYing XuAlexander F. Mericli Clinical trial 16 August 2020 Pages: 345 - 356
Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy Carly Bess WilliamsCaroline A. NebhanAnn Richmond Clinical trial 07 August 2020 Pages: 357 - 364
Patterns in detection of recurrence among patients treated for breast cancer Lena SaltbækTrine Allerslev HorsboelSusanne Oksbjerg Dalton Clinical trial 06 August 2020 Pages: 365 - 373
Single-port laparoscopically harvested omental flap for immediate breast reconstruction Eun-Kyu KimSumin ChaeSang-Hoon Ahn Clinical trial 06 August 2020 Pages: 375 - 384
Local staging of ipsilateral breast tumor recurrence: mammography, ultrasound, or MRI? Coco J. E. F. WalstraRobert-Jan SchipperRegina G. H. Beets-Tan Clinical trial Open access 08 August 2020 Pages: 385 - 395
Efficacy and safety analysis of paclitaxel, docetaxel and liposomal paclitaxel after neoadjuvant therapy in breast cancer Zhao BiPeng ChenYong-Sheng Wang Clinical trial 10 August 2020 Pages: 397 - 405
Accuracy of breast MRI in patients receiving neoadjuvant endocrine therapy: comprehensive imaging analysis and correlation with clinical and pathological assessments Joana ReisJonas Christoffer LindstrømJonn Terje Geitung Clinical trial Open access 12 August 2020 Pages: 407 - 420
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study Francesco SchettiniNavid SobhaniDaniele Generali Clinical trial Open access 07 August 2020 Pages: 421 - 431
Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy Cynthia D’HondtMarian VanhoeijMichel De Vos Clinical trial 13 August 2020 Pages: 433 - 444
Factors associated with falls in older women with breast cancer: the use of a brief geriatric screening tool in clinic David B. BartlettGloria BroadwaterGretchen Kimmick Clinical trial 13 August 2020 Pages: 445 - 457
Reduction of breast lymphoedema secondary to breast cancer: a randomised controlled exercise trial S. L. KilbreathL. C. WardD. Black Clinical trial 18 August 2020 Pages: 459 - 467
Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study) Santiago González-SantiagoCristina SauraJosé Ignacio Chacón Clinical trial 02 September 2020 Pages: 469 - 479
Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP) Sacha J. HowellFaye CoeMaria Ekholm Clinical trial Open access 29 August 2020 Pages: 481 - 489
Using patient perspectives to inform communication training materials for health care professionals discussing BRCA mutation testing Valerie ShillingSusan CattLesley Fallowfield Clinical trial Open access 18 August 2020 Pages: 491 - 498
Increasing accrual of minority patients in breast cancer clinical trials Amelia A. TrantLucas WalzAndrea Silber Clinical trial 25 August 2020 Pages: 499 - 505
A population-based study of invitation to and participation in clinical trials among women with early-stage breast cancer Monica A. PatelJennifer L. ShahChristine M. Veenstra Epidemiology 05 August 2020 Pages: 507 - 518
Early stage breast cancer treatment and outcome of older patients treated in an oncogeriatric care and a standard care setting: an international comparison Anna Z. de BoerWillemien van de WaterMartine Extermann Epidemiology Open access 19 August 2020 Pages: 519 - 526
Characteristics and prognosis of 17 special histologic subtypes of invasive breast cancers according to World Health Organization classification: comparative analysis to invasive carcinoma of no special type Jiyoung KimJee Ye KimKorean Breast Cancer Society Epidemiology 13 August 2020 Pages: 527 - 542
Risk factors for inflammatory and non-inflammatory breast cancer in North Africa Catherine SchairerAhmed HablasAmr S. Soliman Epidemiology 02 September 2020 Pages: 543 - 558
Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine Shayma KazmiDebanjana ChatterjeePeter A. Kaufman Epidemiology Open access 17 August 2020 Pages: 559 - 565
Physicians’ attitudes towards reproduction in young patients with early breast cancer in China Yuzhu ZhangLiping DianRui Xu Epidemiology Open access 10 August 2020 Pages: 567 - 583
Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a comparative registry-based study Rin OgiyaNaoki NiikuraHiromitsu Jinno Epidemiology 20 August 2020 Pages: 585 - 596
Nomograms for prediction of overall and cancer-specific survival in young breast cancer Yi SunYuqiang LiFengyan Yu Epidemiology 04 September 2020 Pages: 597 - 613
Isoflavone intake on the risk of overall breast cancer and molecular subtypes in women at high risk for hereditary breast cancer Eun Ji SimKwang-Pil KoSue K. Park Epidemiology 17 October 2020 Pages: 615 - 626
Analyzing non-sentinel axillary metastases in patients with T3–T4 cN0 early breast cancer and tumor-involved sentinel lymph nodes undergoing breast-conserving therapy or mastectomy Fabian RiedelJoerg HeilAndré Hennigs Epidemiology Open access 20 August 2020 Pages: 627 - 636
Management of early breast cancer during the COVID-19 pandemic in Brazil Francisco Pimentel CavalcanteGuilherme Garcia NovitaRuffo Freitas Junior Epidemiology 16 August 2020 Pages: 637 - 647
Association of RAD51C germline mutations with breast cancer among Bahamians Maryam BagherzadehAgata SzymiczekMohammad R. Akbari Brief Report 18 August 2020 Pages: 649 - 651
Letter to the editor Re: Pan et al. "LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer" Renba Liang Letter to the Editor 14 August 2020 Pages: 653 - 653